$NRXS News

NeurAxis (NRXS) Climbs on Reimbursement and Guideline Momentum

NeurAxis Stock Gains Post Q1 Earnings, Revenues and Margin Surge Y/Y

Neuraxis Inc (NRXS) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amid Coverage Challenges

NeurAxis, Inc. (NRXS) Q1 2026 Earnings Call Transcript

NeurAxis (NRXS) Q1 2026 Revenue and EPS Beat Drive Record Revenue and Strong Pre-Market Gains

Neuraxis Reports Q1 2026 Results: Full Earnings Call Transcript

NeurAxis Reports Record First Quarter 2026 Financial Results Driven by 80% Year Over Year Revenue Growth

Neuraxis Q1 EPS $(0.18) Beats $(0.19) Estimate, Sales $1.607M Beat $1.450M Estimate

NeurAxis to Host First Quarter 2026 Results and Business Update Call on Tuesday, May 12, 2026

NeurAxis Inc (NYSEARCA:NRXS) Shows Strong Technical and Fundamental Momentum

NeurAxis Expands Payer Coverage with Four New Medical Policies

NeurAxis, Inc. Announces Preferred Stock Dividend

NeurAxis Stock Gains Post Q4 Earnings on Strong Revenue Growth

Craig-Hallum Maintains Buy on Neuraxis, Raises Price Target to $13

Neuraxis Inc (NRXS) Q4 2025 Earnings Call Highlights: Revenue Growth Amidst Operational Challenges

NeurAxis, Inc. (NRXS) Q4 2025 Earnings Call Transcript

NeurAxis, Inc. Q4 2025 Earnings Call Summary

NeurAxis Inc (NYSEARCA:NRXS) Reports Q4 Revenue Beat Amid Mixed Market Reaction

NeurAxis Reports Strong Fourth Quarter and Full Year 2025 Financial Results

Neuraxis Q4 EPS $(0.17) Beats $(0.21) Estimate, Sales $968.127K Beat $850.000K Estimate